CARBIDOPA, LEVODOPA AND ENTACAPONE 150 mg/1 (Carbidopa, Levodopa and Entacapone TABLET, FILM COATED) 150 mg/1

Carbidopa, Levodopa, and Entacapone 150 mg/1 is a combination medication used to manage symptoms of Parkinson's disease. This oral tablet helps improve movement and reduce tremors by increasing dopamine levels in the brain.

Strength

150 mg/1

Pack Size

100 TABLET, FILM COATED in 1 BOTTLE (16571-693-01)

Manufacturer / TM Owner

Rising Pharma Holdings, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Carbidopa, Levodopa, and Entacapone 150 mg/1 is primarily used to treat Parkinson's disease. It works by increasing the levels of dopamine, a chemical messenger in the brain that helps control movement. This medication is often prescribed to alleviate symptoms such as tremors, stiffness, and difficulty with walking and coordination. It is important to follow the advice of a healthcare professional regarding the use of this medication.

Side Effects

Common effects of Carbidopa, Levodopa, and Entacapone 150 mg/1 may include nausea, dizziness, and headache. Some users might experience insomnia or unusual movements. These effects can vary from person to person and may diminish over time as the body adjusts to the medication.

Precautions & Warnings

Carbidopa, Levodopa, and Entacapone 150 mg/1 should be handled with care. It is important to store the medication in a cool, dry place away from direct sunlight. Always follow the storage instructions provided by the manufacturer. Consult a healthcare professional before starting this medication, especially if you have any pre-existing medical conditions or are taking other medications.

Avoid Interactions

Carbidopa, Levodopa, and Entacapone 150 mg/1 may interact with certain medications, including other Parkinson's disease treatments, antidepressants, and blood pressure medications. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while taking this medication.

Frequently Asked Questions

Carbidopa, Levodopa, and Entacapone 150 mg/1 is used to manage symptoms of Parkinson's disease, such as tremors, stiffness, and difficulty with movement.

This medication is taken orally, typically as directed by a healthcare professional. Always follow the prescribed dosage and administration instructions.

Common side effects may include nausea, dizziness, headache, and insomnia. These effects can vary and may diminish over time.

It is generally advised to avoid alcohol while taking this medication to prevent potential interactions and side effects.

Store this medication in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.